Seres Therapeutics, Inc.
$2.46
-0.07 (-2.77%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -40.0%
- 3 Months
- -51.9%
- YTD
- -83.5%
- 1 Year
- -87.5%
- 3 Year annualized
- -56.2%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 89.6%
- Largest decline max drawdown, since Oct 2021
- -98.9%
- Risk-adjusted return Sharpe ratio, 1-year
- -1.83
Own MCRB?
See how MCRB contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.